12.16.2014 Biotech IP Attorney Dr. David M. Saravitz Joins Williams Mullen
Williams Mullen is pleased to announce that David M. Saravitz, Ph.D., has joined Williams Mullen as a Partner in the Intellectual Property section. He will be working out of the Raleigh office.
Dr. Saravitz has extensive knowledge in the life sciences, including industry and university research, as well as more than 15 years of experience in intellectual property law. He focuses his practice on the particular IP challenges facing the biotechnology/life sciences industry, helping his clients protect their intellectual property assets to best grow their businesses. Dr. Saravitz advises on general patent counseling, strategic planning, opinions concerning patentability, freedom to operate and infringement, IP-related due diligence in business transactions, patent licensing, and patent application drafting and prosecution and is admitted to practice before the United States Patent and Trademark Office.
“The life sciences industry is significant and growing in the Triangle and throughout North Carolina, and a company’s ability to successfully protect and leverage its intellectual property is critical to that growth,” said David Paulson, North Carolina Managing Partner. “David has the ability to understand both the hyper-technical and practical business aspects of biotech IP. We are delighted to have him join our integrated team of corporate and IP lawyers, helping us continue to develop as a local, sophisticated one-stop shop for technology companies that want their IP and business lawyers under one roof.”
In addition to earning a J.D. from the North Carolina Central University School of Law, Dr. Saravitz’s background includes a Ph.D. in cell and molecular biology from Duke University, an M.S. from North Carolina State University and a B.S., with distinction, from The Pennsylvania State University. At law school, he served as chairperson of the Intellectual Property Law Society. While studying at Duke, Dr. Saravitz was the recipient of both a National Institutes of Health Cell and Molecular Biology Training Grant and a Plant Molecular Biology Fellowship from the North Carolina Biotechnology Center.